DENNIS DUNCAN: Open Payments
NPI 1417229816 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$682 in 39 payments from 12 companies in 2025. Trend: 2023 $1,576 · 2024 $1,203 · 2025 $682
Food & beverage: $682
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $183 |
| Novo Nordisk Inc | 4 | $101 |
| Lilly USA, LLC | 5 | $89 |
| GlaxoSmithKline, LLC. | 4 | $87 |
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
| Dexcom, Inc. | 1 | $38 |
| PFIZER INC. | 2 | $28 |
| Lundbeck LLC | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
Products named: OTEZLA, AREXVY, MOUNJARO, Ozempic, Rybelsus, Dexcom G6 Transmitter, KISUNLA, REPATHA.
Industry payments across VA — which companies pay providers there.
